Nu Skin Enterprises (NYSE:NUS) Upgraded at Zacks Research

Nu Skin Enterprises (NYSE:NUS) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks reports.

Separately, Weiss Ratings downgraded shares of Nu Skin Enterprises from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Nu Skin Enterprises presently has a consensus rating of “Reduce”.

Nu Skin Enterprises Price Performance

Shares of NYSE:NUS opened at $5.01 on Monday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.24 and a current ratio of 1.98. The firm has a fifty day moving average price of $4.78 and a 200 day moving average price of $5.62. Nu Skin Enterprises has a fifty-two week low of $4.45 and a fifty-two week high of $11.67. The firm has a market cap of $244.13 million, a price-to-earnings ratio of -1.12 and a beta of 0.91.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Monday, August 10th. The company reported $0.20 earnings per share for the quarter, meeting the consensus estimate of $0.20. The company had revenue of $320.11 million during the quarter, compared to analysts’ expectations of $345.20 million. Nu Skin Enterprises had a negative net margin of 15.73% and a positive return on equity of 6.58%. Nu Skin Enterprises has set its FY 2026 guidance at 0.700-0.900 EPS and its Q3 2026 guidance at 0.100-0.200 EPS. As a group, sell-side analysts expect that Nu Skin Enterprises will post 0.82 earnings per share for the current fiscal year.

Institutional Trading of Nu Skin Enterprises

Several hedge funds have recently modified their holdings of the company. Corient Private Wealth LP bought a new position in shares of Nu Skin Enterprises during the 2nd quarter valued at approximately $54,000. Public Employees Retirement System of Ohio bought a new stake in Nu Skin Enterprises in the second quarter worth $132,000. Pinnacle Holdings LLC bought a new stake in Nu Skin Enterprises in the second quarter worth $48,000. Empowered Funds LLC increased its position in Nu Skin Enterprises by 16.9% in the first quarter. Empowered Funds LLC now owns 282,398 shares of the company’s stock worth $2,056,000 after purchasing an additional 40,728 shares during the last quarter. Finally, Lazard Asset Management LLC raised its stake in Nu Skin Enterprises by 88.0% during the first quarter. Lazard Asset Management LLC now owns 330,647 shares of the company’s stock valued at $2,407,000 after purchasing an additional 154,814 shares in the last quarter. 82.84% of the stock is owned by hedge funds and other institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc (NYSE:NUS) is a global direct-selling company that develops and markets personal care, beauty and wellness products. Its portfolio includes skincare products, nutritional supplements and beauty devices sold under brands such as Nu Skin, ageLOC and Pharmanex.

The company distributes its products primarily through a network of independent sales representatives, supported by digital commerce and other direct-selling channels. Nu Skin serves customers across markets in the Americas, Asia-Pacific, Europe, Africa and the Middle East, with product offerings and operations varying by region.

Founded in 1984 and headquartered in Provo, Utah, Nu Skin has built its business around research-supported skincare and nutritional products, including anti-aging and wellness-focused offerings.